FDA to approve Carticel cartilage repair service
This article was originally published in Clinica
The FDA has issued an approvable letter for Genzyme Tissue Repair's knee cartilage repair service Carticel. Final approval is expected in July or August. Carticel has been sold unregulated since July 1995, when the FDA ruled that it fell outside existing regulations.